Email This Article
Headlines & Perspectives
Onyx Pharma Swings to Outsized Profit
By
Elizabeth Trotta
05/06/08 - 05:09 PM EDT
The biotech company trounces Wall Street expectations for the first quarter on sales gains of Nexavar.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
Sign up for our FREE newsletters now.
Keep on top of the market and the critical information you need to make more profitable investing decisions.
Find more premium investing ideas